Shattuck Labs, Inc. (STTK)

4.2600 -0.1000 (-2.29%) At close: 04:00PM EST

Shattuck Labs, Inc.

500 West 5th Street
Suite 1200
Austin, TX 78703
United States
512 900 4690
https://www.shattucklabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 85

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Taylor H. Schreiber M.D., Ph.D.	Co-Founder, CEO & Director	744.45k	N/A	1980
Dr. Arundathy Nirmalini Pandite M.B.A., M.D.	Chief Medical Officer	638.44k	N/A	1959
Ms. Casi DeYoung	Chief Bus. Officer	523.48k	N/A	1971
Mr. Andrew R. Neill M.B.A.	Chief Financial Officer	N/A	N/A	1986
Dr. Abhinav A. Shukla Ph.D.	Chief Technical Officer	N/A	N/A	1973
Mr. Conor Richardson CPA	VP of Investor Relations	N/A	N/A	N/A
Ms. Erin Ator Thomson J.D.	Gen. Counsel, Corp. Sec. and Chief Ethics & Compliance Officer	N/A	N/A	1980
Dr. Thomas Lampkin Pharm.D.	Sr. VP of Regulatory Affairs	N/A	N/A	N/A
Ms. Fatima Rangwala M.D., Ph.D.	Sr. VP of Clinical Research	N/A	N/A	N/A
Mr. George Fromm Ph.D.	Chief Scientific Officer of ARC Platform	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Corporate governance

Shattuck Labs, Inc.’s ISS governance QualityScore as of 1 February 2023 is 7. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.